US Patent

US8962829 — Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof

Composition of Matter · Assigned to Chimerix Inc · Expires 2034-10-10 · 8y remaining

Vulnerability score 4/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects methods of synthesizing phosphonate ester compounds and their morphic forms, allowing for large-scale preparation with high purity and stability.

USPTO Abstract

The disclosure describes methods of synthesis of phosphonate ester compounds. The methods according to the disclosure allow for large-scale preparation of phosphonate ester compounds having high purity and stability. Also disclosed are morphic forms of phosphonate ester compounds.

Drugs covered by this patent

Patent Metadata

Patent number
US8962829
Jurisdiction
US
Classification
Composition of Matter
Expires
2034-10-10
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Chimerix Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.